enGene Therapeutics (ENGN) Shares Outstanding (Diluted) (2022 - 2026)
enGene Therapeutics' Shares Outstanding (Diluted) came in at 69.73 million for fiscal Q3 2026 (quarter ended Jul 31, 2026), up 36.5% from 51.1 million a year earlier and unchanged from the prior quarter.
Powered by 
Analysis
enGene Therapeutics (ENGN) Shares Outstanding (Diluted) (2022 - 2026) Analysis & Trends
For FY2025 (ended Oct 31, 2025), enGene Therapeutics' Shares Outstanding (Diluted) was 51.12 million, up 35.3% from FY2024.
- Shares Outstanding (Diluted) carries a three-year compound annual growth rate of 327.3% (FY2022 to FY2025).
- Going back by fiscal year, Shares Outstanding (Diluted) was 37.78 million in FY2024, 692,609 in FY2023 (+5.7%) and 655,153 in FY2022.
- The fiscal Q3 2026 figure represents the highest quarterly Shares Outstanding (Diluted) in data going back to fiscal Q4 2022.
- Year-over-year, Shares Outstanding (Diluted) has increased for seven consecutive quarters, with growth averaging 43.6% over the last seven quarters.
- Over the past five years, the year-over-year growth in Shares Outstanding (Diluted) ranged from 5.7% (fiscal Q4 2023) to 119.7% (fiscal Q1 2025).
- Business Quant data shows ENGN's Shares Outstanding (Diluted) at 69.72 million (Q2 2026), 67.26 million (Q1 2026) and 51.12 million (Q4 2025) in the three fiscal quarters before Q3 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Dil.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 2.44 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 1.77 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 2.47 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 1.96 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 1.56 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 544.00 Mn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 1.24 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 5.70 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 255.20 Mn |
| 10 | enGene Therapeutics | 134.03 Mn | 134.03 Mn | - | 69.73 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jul 31, 2026 | 69.73 Mn |
| Apr 30, 2026 | 69.72 Mn |
| Jan 31, 2026 | 67.26 Mn |
| Oct 31, 2025 | 51.12 Mn |
| Jul 31, 2025 | 51.10 Mn |
| Apr 30, 2025 | 51.02 Mn |
| Jan 31, 2025 | 50.98 Mn |
| Oct 31, 2024 | 37.78 Mn |
| Jul 31, 2024 | 44.17 Mn |
| Apr 30, 2024 | 39.44 Mn |
| Jan 31, 2024 | 23.20 Mn |
| Oct 31, 2023 | 692,609.00 |
| Jul 31, 2023 | 701,323.00 |
| Apr 30, 2023 | 694,497.00 |
| Jan 31, 2023 | 651,074.00 |
| Oct 31, 2022 | 655,153.00 |
API Access
enGene Therapeutics Shares Outstanding (Diluted) API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=shares-outstanding-diluted&ticker=ENGN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "shares-outstanding-diluted", "ticker": "ENGN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=shares-outstanding-diluted&ticker=ENGN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();